Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 4 (2007), Issue 9 (September)

1. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.
   Exp Mol Pathol, 83(2): 207-15. [Abstract] [Full-text]
2. Comfort and efficacy of a longer and thinner endoscope for average risk colon cancer screening.
   Dig Dis Sci, 52(10): 2892-6. [Abstract] [Full-text]
3. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers.
   Dig Dis Sci, 52(10): 2775-83. [Abstract] [Full-text]
4. Malignancy risk of small polyps and related factors.
   Dig Dis Sci, 52(10): 2796-9. [Abstract] [Full-text]
5. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells.
   J Control Release, 122(2): 151-8. [Abstract] [Full-text]
6. Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects.
   Biochem Biophys Res Commun, 362(3): 606-11. [Abstract] [Full-text]
7. Identification of consensus genes and key regulatory elements in 5-fluorouracil resistance in gastric and colon cancer.
   Onkologie, 30(8): 421-6. [Abstract] [Full-text]
8. In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines.
   Br J Cancer, 97(6): 745-54. [Abstract] [Full-text]
9. Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model.
   Cancer Gene Ther, 14(10): 867-72. [Abstract] [Full-text]
10. Colorectal cancer screening in elderly patients: when should be more useful?
    Cancer Treat Rev, 33(6): 528-32. [Abstract] [Full-text]
11. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP).
    Hum Mutat, 28(10): 985-92. [Abstract] [Full-text]
12. Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy.
    Cell Prolif, 40(5): 768-79. [Abstract] [Full-text]
13. Expression and characterization of a human carboxylesterase 2 splice variant.
    J Pharmacol Exp Ther, 323(1): 94-101. [Abstract] [Full-text]
14. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC).
    Int J Cancer, 121(9): 2065-72. [Abstract] [Full-text]
15. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.
    Int J Cancer, 121(9): 2013-22. [Abstract] [Full-text]
16. Protein phosphorylation analysis by site-specific arginine-mimic labeling in gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Anal Biochem, 370(1): 77-86. [Abstract] [Full-text]
17. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
    J Surg Res, 142(2): 239-45. [Abstract] [Full-text]
18. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.
    Ann Surg, 246(4): 655-62; discussion 662-4. [Abstract] [Full-text]
19. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
    Ann Surg, 246(4): 568-75; discussion 575-7. [Abstract] [Full-text]
20. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice.
    J Cell Biol, 178(7): 1109-20. [Abstract] [Full-text]
21. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
    Cancer, 110(7): 1469-77. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.